GlassScriptPhysician profile
Lawrence R Miller
NPI 1902879067
$11,642.29
in general payments reported to CMS, 2019-2025
45 companies · $1,395 in 2025
The $1,395 reported for 2025 was more than what 79% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,084 · 2020: $1,203 · 2021: $2,329 · 2022: $2,288 · 2023: $2,008 · 2024: $1,336 · 2025: $1,395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,739.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,739.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,258.35 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Clik X |
| Abbvie INC. | $2,057.25 | 2021-2025 | |
| Electronic Waveform Lab, INC. | $1,678.98 | 2019-2025 | |
| Medtronic, INC. | $862.77 | 2021-2024 | Intellis Adaptivestim |
| Philips North America LLC | $759.48 | 2021-2023 | |
| Merz Pharmaceuticals, LLC | $507.20 | 2021-2023 | Xeomin |
| Pfizer INC. | $411.45 | 2023-2025 | |
| Nalu Medical, INC. | $323.34 | 2023-2024 | Nalu Neurostimulation System |
| Allergan, INC. | $188.53 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $186.31 | 2019-2025 | Relistor |
| Virtus Pharmaceuticals LLC | $165.70 | 2021-2025 | Levorphanol Tartrate |
| Almatica Pharma LLC | $161.91 | 2021-2023 | Gralise |
| Scilex Pharmaceuticals INC. | $152.43 | 2019-2023 | Ztlido |
| Sentynl Therapeutics, INC. | $148.64 | 2019-2020 | |
| Hologic Sales and Service, LLC | $147.18 | 2022 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.